GU Cancers 2020 | SAUL analysis: atezolizumab in urothelial carcinoma patients

Name: SAUL analysis: atezolizumab in urothelial carcinoma patients
Uploaded: 2020-02-13T00:00:00.000Z
Duration: 1 min 13 s
Description: Cora Sternberg, MD, FACP, Weill Cornell Medicine, New York, NY, discusses the subgroup analysis of the single-arm international SAUL study (NCT02928406) in pretreated locally advanced urinary tract carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Cora Sternberg • 13 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer Atezolizumab

SAUL

Cora Sternberg, MD, FACP, Weill Cornell Medicine, New York, NY, discusses the subgroup analysis of the single-arm international SAUL study (NCT02928406) in pretreated locally advanced urinary tract carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.